• prophylaxis
  • This is a prospective, open-label, multicenter, and observational study executed in 20 organizations nationwide with around 250 patients, in order to examine the correlation between a sufficient blood concentration of itraconazole and disappearance of a fever (defeverscence) when a itraconazole injection is administered for resolving unknown neutropenic fever of patients who are given itraconazole oral solution as a prophylaxis under general treatment conditions. (knowcancer.com)
  • Interactions
  • There are potential interactions between the efavirenz and itraconazole- ones that increase the efavirenz levels and decrease the itraconazole levels- as a result, this won't compromise the effectiveness of the HIV medications, only potentially increase the risk of side effects. (thebody.com)
  • dose
  • However, elderly patients are more likely to have temporary or permanent hearing loss or have kidney, liver, or heart problems, which may require caution and an adjustment in the dose for patients receiving itraconazole. (mayoclinic.org)
  • Itraconazole consistently showed potent, specific, and dose-dependent inhibition of endothelial cell proliferation, migration, and tube formation in response to both VEGF- and basic fibroblast growth factor-mediated angiogenic stimulation. (aacrjournals.org)
  • HPLC
  • This article details the elements used in the method verification for the simultaneous high performance liquid chromatography (HPLC) assay of Pentoxifylline, Mupirocin, Itraconazole, and Fluticasone Propionate in Humco™ Lavare Wound base. (mdpi.com)
  • oral solution
  • After the administration for a total of 14 days, itraconazole oral solution 200 mg (20 ml) twice daily should be continued for a total of 14 days until clinically significant resolution of neutropenia resolves. (knowcancer.com)
  • daily
  • Participants with SFI received 200 milligram (mg) twice daily itraconazole intravenous (into the vein) infusion (ITCZ-IV) for first 2 days followed by 200 mg per day ITCZ-IV up to 14 days. (clinicaltrials.gov)
  • extensive
  • The extensive Global Itraconazole Powder Industry survey report covers other key information such as the values and facts of the market such as revenue, volume, market share for each region, and revenue and market share of key players in the market. (medgadget.com)
  • professional
  • In our aim to bring the best and complete information to our clients, we at Orbis Research present the 2017 Global Itraconazole Powder Market professional survey. (medgadget.com)
  • details
  • This report details the method verification requirements and corresponding acceptance criteria for the analytical method used to assay Pentoxifylline, Mupirocin, Itraconazole, and Fluticasone Propionate compounded in Humco™ Lavare wound base. (mdpi.com)
  • analysis
  • Owing to the thorough nature of the survey report, it contains an in-depth analysis of the market for the global Itraconazole Powder market as well as for individual regions. (medgadget.com)
  • Cost structure analysis and manufacturing plans analysis for all parameters is covered in detail in the Global Itraconazole Powder Market survey report. (medgadget.com)
  • The competition analysis and regional market analysis are the mainstay of the Global Itraconazole Powder Industry survey report. (medgadget.com)
  • The survey also covers Itraconazole Powder Industry analysis by type and application, and concluding with a SWOT analysis and investment feasibility analysis of the market. (medgadget.com)
  • As with every report put up on Orbis Research, the Itraconazole Powder Market survey report aims to meet the client requirements in terms of complete information and analysis of the market. (medgadget.com)